A number of immunoinflammatory and profibrotic mechanisms are recognized in the
pathogenesis of broad sclerotic skin processes and, more specifically, morphoea. However …

Scleroderma (morphea) en coup de sabre is a localized subtype restricted to the
frontoparietal region of the head. Current treatment paradigms rely on low levels of …

La livedo es una manifestación cutánea frecuente, que consiste en un eritema reticular de
origen vascular. Las dermatosis no vasculares con una disposición reticulada se reconocen …

Systemic and localized scleroderma are difficult to manage diseases with no accepted gold
standard of therapy to date. Phototherapeutic modalities for scleroderma show promise. A …

Hydroxychloroquine (HCQ) is a commonly used therapeutic agent in skin disorders. Some
reports also suggest that HCQ can be useful in fibroblastic diseases of the skin. Here, we …

New developments in localized scleroderma : Current Opinion in Rheumatology New
developments in localized scleroderma : Current Opinion in Rheumatology Log in or …

Morphea or localized scleroderma is a rare fibrosing disorder of the skin and underlying
tissues. It is an inflammatory disorder characterized by skin hardening caused by increased …

Scleroderma or progressive systemic sclerosis is diagnosed clinically by typical features of
skin thickening, Raynaud's phenomenon and visceral organ involvement, and serologically …

An overview of the most common or important dermatoses occurring in the first year of life is
presented, under the categories of inflammatory, infective, reactive, developmental/genetic …

The use of blunt-tipped microcannulas for the injection of soft tissue fillers offers an option for
less traumatic facial augmentation. The ability to treat large areas with few entry points …